Astria Therapeutics, Inc. (ATXS)

NASDAQ: ATXS · Real-Time Price · USD

5.40

+0.06 (1.12%)

Apr 1, 2025, 4:00 PM EDT - Market closed

Astria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	305	505	279	389	70	43	Upgrade
Market Cap Growth	80.99%	80.99%	-28.37%	454.95%	63.15%	-38.35%	Upgrade
Enterprise Value	-18	261	186	370	35	-9	Upgrade
Last Close Price	5.40	8.94	7.68	14.89	5.39	12.84	Upgrade
PB Ratio	1.36	1.58	1.15	1.76	0.57	1.06	Upgrade
P/TBV Ratio	2.25	2.25	1.89	3.12	2.71	1.06	Upgrade
Debt / Equity Ratio	0.02	0.02	0.00	0.00	0.00	0.03	Upgrade
Quick Ratio	17.15	17.15	21.35	24.99	24.12	7.03	Upgrade
Current Ratio	17.49	17.49	21.73	25.13	24.42	7.25	Upgrade
Return on Equity (ROE)	-33.52%	-33.52%	-31.40%	-30.18%	-239.18%	-97.66%	Upgrade
Return on Assets (ROA)	-23.36%	-23.36%	-17.47%	-18.67%	-21.69%	-52.44%	Upgrade
Return on Capital (ROIC)	-24.55%	-24.55%	-18.21%	-19.39%	-23.08%	-58.72%	Upgrade
Earnings Yield	-30.93%	-18.68%	-26.15%	-13.32%	-277.97%	-86.78%	Upgrade
FCF Yield	-26.76%	-16.16%	-24.56%	-11.21%	-43.03%	-75.66%	Upgrade
Buyback Yield / Dilution	-86.44%	-86.44%	-106.03%	-63.81%	-191.81%	-63.87%	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q